← All trials
NCT06111326
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 31, 2023
- Primary completion
- Aug 31, 2024
- Completion date
- May 31, 2026
- First posted
- Nov 1, 2023
- Last posted
- Nov 1, 2023
- Enrollment
- 83
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Biocity Biopharmaceutics Co., Ltd.Lead sponsor
- Fudan UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.